NDC 70518-3582-2 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3582
- Requested NDC
- 70518-3582-2
- Package NDCs from labels
- 70518-3582-2, 70518-3582-0, 70518-3582-5, 70518-3582-4, 70518-3582-3, 70518-3582-6, 70518-3582-8, 70518-3582-7, 70518-3582-1, 70518-3582-9
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2022-12-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - REMEDYREPACK INC. | REMEDYREPACK INC. | 2022-12-27 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PaxLyte | LEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE CAPSULE | Jaymac Pharmaceuticals | f520b130-61b3-443e-aaf6-91e094e7a334 | 2025-12-08 | Warnings, Adverse reactions | 2968PHW8QP |
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 2968PHW8QP |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 2968PHW8QP |
| Levetiracetam | LEVETIRACETAM | Guardian Drug Company | e77162ff-0ff9-45ca-95fc-da6ea24ce5a2 | 2025-12-02 | Warnings, Adverse reactions | 44YRR34555 |
| BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASK | BUTYLENE GLYCOL, GLYCERIN, INONOTUS OBLIQUUS (MUSHROOM) EXTRACT | BUDDATE Co Ltd | 464988ad-557e-13f5-e054-00144ff8d46c | 2025-11-30 | Warnings | PDC6A3C0OX |
| BUDDATE LOTUS MOISTURE ESSENCE | GLYCERIN, NIACINAMIDE, NELUMBO NUCIFERA FLOWER EXTRACT, PORTULACA OLERACEA EXTRACT | BUDDATE Co Ltd | 46499995-8b13-3e5c-e054-00144ff88e88 | 2025-11-30 | Warnings | PDC6A3C0OX |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Levetiracetam Extended-Release | LEVETIRACETAM | Golden State Medical Supply, Inc. | 5dde1889-a217-4493-9a71-9fd39ed04630 | 2025-11-24 | Warnings, Adverse reactions | 44YRR34555 |
| Rain Daily Hydration and Comfort For Dry Eyes | GLYCERIN | Rain Eye Drops, LLC | 31d7c204-fb74-fb28-e063-6294a90ab330 | 2025-11-23 | Warnings | PDC6A3C0OX |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 6e31e766-6504-4f20-8831-1953363cace0 | 2025-11-21 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hp Halden Pharma AS | 1d9abcce-8ef7-422b-bf4b-5835bf4dbb34 | 2025-11-21 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hp Halden Pharma AS | 6951de41-4a16-4cca-8039-44fc81407081 | 2025-11-21 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.